Neurocrine Biosciences shares owned by Rhenman & Partners Asset Management AB
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Rhenman & Partners Asset Management AB
from 13F filings
Historical chart of Rhenman & Partners Asset Management AB investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences by Rhenman & Partners Asset Management AB
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $8.3M | 72k | 115.22 |
2024-06-30 | $10M | 76k | 137.67 |
2024-03-31 | $8.1M | 59k | 137.92 |
2023-09-30 | $3.8M | 40k | 94.30 |
2023-06-30 | $3.8M | 40k | 94.30 |
2023-03-31 | $6.9M | 70k | 99.21 |
2022-12-31 | $10M | 85k | 119.44 |
2022-09-30 | $9.6M | 83k | 115.12 |
2022-06-30 | $9.3M | 95k | 97.48 |
2022-03-31 | $9.8M | 105k | 93.75 |
2021-12-31 | $13M | 151k | 84.63 |
2021-09-30 | $9.1M | 95k | 95.91 |
2021-06-30 | $10M | 105k | 97.32 |
2021-03-31 | $15M | 155k | 97.25 |
2020-12-31 | $14M | 150k | 95.85 |
2020-09-30 | $7.2M | 75k | 96.16 |
2020-06-30 | $9.2M | 75k | 122.00 |
2020-03-31 | $11M | 130k | 86.55 |
2019-12-31 | $13M | 120k | 107.49 |
2019-09-30 | $14M | 150k | 90.11 |
2019-06-30 | $15M | 180k | 84.43 |
2019-03-31 | $16M | 177k | 88.10 |
2018-12-31 | $14M | 201k | 71.41 |
2018-09-30 | $10M | 82k | 122.95 |
2018-06-30 | $11M | 110k | 98.24 |
2018-03-31 | $9.1M | 110k | 82.93 |
2017-12-31 | $9.2M | 118k | 77.59 |
2017-09-30 | $7.0M | 115k | 61.28 |
2017-06-30 | $5.5M | 120k | 46.00 |
2017-03-31 | $3.7M | 85k | 43.31 |
2016-12-31 | $1.5M | 40k | 38.70 |
2016-09-30 | $2.0M | 40k | 50.64 |
2016-06-30 | $1.8M | 40k | 45.45 |
2016-03-31 | $2.4M | 60k | 39.55 |
More positions owned by Rhenman & Partners Asset Management AB
View all positions for Rhenman & Partners Asset Management AB